Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Ares-Serono's Rebif shows promising results in three-year SPMS trial

June 10, 1999

Lundbeck and Neurochem to conduct joint AD research

June 10, 1999

Novel anticonvulsants designed by Howard University scientists

June 9, 1999

Anticonvulsant isoquinoline series described in recent patent literature by SmithKline Beecham

June 9, 1999

Selective alpha2-adrenoceptor antagonists developed at Pierre Fabre for neurodegenerative disorders

June 9, 1999

Behavioral effects of NOS inhibitor studied in rat model

June 9, 1999

FDA approves IND for Adolor's novel analgesic

June 9, 1999

First new narcolepsy agent in four decades introduced in Canada

June 8, 1999

CoCensys granted patent for noncompetitive AMPA receptor antagonists and their use

June 8, 1999

Lilly's new 5-ht1f agonists especially useful for migraine

June 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...